Skip to main content

and
  1. No Access

    Article

    The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development

    Increasing evidence suggests that mesenchymal stem/stromal cells (MSCs) carrying specific mutations are at the origin of some sarcomas. We have reported that the deficiency of p53 alone or in combination with ...

    R Rubio, I Gutierrez-Aranda, A I Sáez-Castillo, A Labarga, M Rosu-Myles in Oncogene (2013)